Suppr超能文献

p16(INK4A)和p57(KIP2)的甲基化与胃黏膜相关淋巴组织淋巴瘤的发生发展有关。

Methylation of p16(INK4A) and p57(KIP2) are involved in the development and progression of gastric MALT lymphomas.

作者信息

Min Ki Ouk, Seo Eun Joo, Kwon Hi Jeong, Lee Eui Jin, Kim Won Il, Kang Chang Suk, Kim Kyoung-Mee

机构信息

Department of Clinical Pathology, The Catholic University of Korea, College of Medicine, Inchon, Korea.

出版信息

Mod Pathol. 2006 Jan;19(1):141-8. doi: 10.1038/modpathol.3800505.

Abstract

p16(INK4A) and p57(KIP2) are inhibitors of cyclin-dependent kinases and their inactivation by methylation has been reported as a major tumorigenic mechanism in tumors. To examine whether methylation of p16(INK4A) and p57(KIP2) is involved in the development and progression of gastric MALT lymphomas, 24 gastric low-grade lymphomas of MALT, 11 diffuse large B-cell lymphomas, and 10 each case of gastric lymphoid follicles with and without Helicobacter pylori infection were studied. H. pylori infection was positive in 85.7% of the gastric lymphomas. In the gastric lymphoid follicles positive for H. pylori, methylation of p16(INK4A) was detected in 10% of cases, while methylation of p57(KIP2) was not detected. In low-grade MALT lymphomas, p16(INK4A) and p57(KIP2) were methylated in 41.7 and 29.2% of the cases, respectively. In diffuse large B-cell lymphomas, methylation of p16(INK4A) and p57(KIP2) was found in 72.7 and 36.4% of the cases, respectively. All but one case with p16(INK4A) and p57(KIP2) methylation was H. pylori positive and most of them were stage I. Our results indicate that methylation of p16(INK4A) followed by p57(KIP2) methylation involves during the tumorigenesis of gastric MALT lymphomas associated with H. pylori infection. As methylation of these two genes was more frequent in the higher grade (P<0.05), it may contribute to the malignant progression of gastric MALT lymphomas.

摘要

p16(INK4A) 和 p57(KIP2) 是细胞周期蛋白依赖性激酶的抑制剂,据报道,它们通过甲基化失活是肿瘤中的一种主要致瘤机制。为了研究 p16(INK4A) 和 p57(KIP2) 的甲基化是否参与胃黏膜相关淋巴组织(MALT)淋巴瘤的发生和发展,对24例胃低度MALT淋巴瘤、11例弥漫性大B细胞淋巴瘤以及10例分别伴有和不伴有幽门螺杆菌感染的胃淋巴滤泡进行了研究。85.7%的胃淋巴瘤中幽门螺杆菌感染呈阳性。在幽门螺杆菌阳性的胃淋巴滤泡中,10%的病例检测到p16(INK4A) 甲基化,而未检测到p57(KIP2) 甲基化。在低度MALT淋巴瘤中,分别有41.7%和29.2%的病例p16(INK4A) 和p57(KIP2) 发生甲基化。在弥漫性大B细胞淋巴瘤中,分别有72.7%和36.4%的病例检测到p16(INK4A) 和p57(KIP2) 甲基化。除1例p16(INK4A) 和p57(KIP2) 甲基化病例外,其余均为幽门螺杆菌阳性,且大多数为I期。我们的结果表明,p16(INK4A) 甲基化随后p57(KIP2) 甲基化参与了与幽门螺杆菌感染相关的胃MALT淋巴瘤的肿瘤发生过程。由于这两个基因的甲基化在高级别肿瘤中更常见(P<0.05),它可能有助于胃MALT淋巴瘤的恶性进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验